Novavax (NVAX) Exchange Rate Effect (2013 - 2026)
Novavax (NVAX) recorded quarterly Exchange Rate Effect of -$18000.0 in Q1 2026, up 98.95% quarter-over-quarter from -$1.7 million in Q4 2025, and up 98.06% on a YoY basis from -$9087.9 in Q1 2025.
Novavax (NVAX) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Novavax's Exchange Rate Effect history runs 14 years deep, the most recent figure standing at -$18000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 98.06% year-over-year to -$18000.0; the TTM figure through Mar 2026 stood at $6.8 million (up 218.39% YoY), while the FY2025 annual figure was $5.9 million, up 175.96% from the prior year.
- Exchange Rate Effect was -$18000.0 for Q1 2026 at Novavax, up from -$1.7 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $9.3 million in Q3 2023 to a low of -$10.7 million in Q4 2024.
- Historically, Exchange Rate Effect has averaged $347000.0 across 5 years, with a median of -$18000.0 in 2026.
- The sharpest annual moves came in 2023 and 2025: Exchange Rate Effect tumbled 738.11% in 2023, then surged 5167.95% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at $4.3 million in 2022, then tumbled by 31.57% to $2.9 million in 2023, then slumped by 467.4% to -$10.7 million in 2024, then jumped by 84.05% to -$1.7 million in 2025, then jumped by 98.95% to -$18000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$18000.0 (Q1 2026), -$1.7 million (Q4 2025), and $658000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Novavax | 1.49 Bn | 931.98 Mn | 108.82 Mn | -18,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18,000.00 |
| Mar 31, 2026 | -18,000.00 |
| Dec 31, 2025 | -1.71 Mn |
| Dec 31, 2025 | -1.71 Mn |
| Sep 30, 2025 | 658,000.00 |
| Sep 30, 2025 | 658,000.00 |
| Jun 30, 2025 | 7.91 Mn |
| Jun 30, 2025 | 7.91 Mn |
| Mar 31, 2025 | -930,000.00 |
| Mar 31, 2025 | -930,000.00 |
| Dec 31, 2024 | -10.72 Mn |
| Dec 31, 2024 | -10.72 Mn |
| Sep 30, 2024 | 6.03 Mn |
| Sep 30, 2024 | 6.03 Mn |
| Jun 30, 2024 | -156,000.00 |
| Jun 30, 2024 | -156,000.00 |
| Mar 31, 2024 | -2.96 Mn |
| Mar 31, 2024 | -2.96 Mn |
| Dec 31, 2023 | 2.92 Mn |
| Dec 31, 2023 | 2.92 Mn |